Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates
Organic anion transporting polypeptide 2B1 (OATP2B1, gene SLCO2B1 ) is an uptake transporter that is thought to determine drug disposition and in particular, the oral absorption of medications. At present, the clinical relevance of SLCO2B1 genetic variation on pharmacokinetics is poorly understood....
Gespeichert in:
Veröffentlicht in: | Frontiers in pharmacology 2021-09, Vol.12, p.713567-713567 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Organic anion transporting polypeptide 2B1 (OATP2B1, gene
SLCO2B1
) is an uptake transporter that is thought to determine drug disposition and in particular, the oral absorption of medications. At present, the clinical relevance of
SLCO2B1
genetic variation on pharmacokinetics is poorly understood. We sought to determine the functional activity of 5 of the most common missense OATP2B1 variants (c.76_84del, c.601G>A, c.917G>A, c.935G>A, and c.1457C>T) and a predicted dysfunctional variant (c.332G>A)
in vitro
. Furthermore, we measured the basal plasma concentrations of endogenous OATP2B1 substrates, namely estrone sulfate, dehydroepiandrosterone sulfate (DHEAS), pregnenolone sulfate, coproporphyrin I (CPI), and CPIII, and assessed their relationships with
SLCO2B1
genotypes in 93 healthy participants. Compared to reference OATP2B1, the transport activities of the c.332G>A, c.601G>A and c.1457C>T variants were reduced among the substrates examined (estrone sulfate, DHEAS, CPI, CPIII and rosuvastatin), although there were substrate-dependent effects. Lower transport function of OATP2B1 variants could be explained by diminished cell surface expression. Other OATP2B1 variants (c.76-84del, c.917G>A and c.935G>A) had similar activity to the reference transporter. In the clinical cohort, the
SLCO2B1
c.935G>A allele was associated with both higher plasma CPI (42%) and CPIII (31%) concentrations, while
SLCO2B1
c.917G>A was linked to lower plasma CPIII by 28% after accounting for the effects of age, sex, and
SLCO1B1
genotypes. No association was observed between
SLCO2B1
variant alleles and estrone sulfate or DHEAS plasma concentrations, however 45% higher plasma pregnenolone sulfate level was associated with
SLCO2B1
c.1457C>T. Taken together, we found that the impacts of OATP2B1 variants on transport activities
in vitro
were not fully aligned with their associations to plasma concentrations of endogenous substrates
in vivo
. Additional studies are required to determine whether circulating endogenous substrates reflect OATP2B1 activity. |
---|---|
ISSN: | 1663-9812 1663-9812 |
DOI: | 10.3389/fphar.2021.713567 |